AT Bancorp’s Novartis NVS Stock Holding History

AT Bancorp’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$277K	Sell	3,220 -228	-7%	-$18.3K	0.03%	206
2018 Q4	$265K	Buy	3,448 +73	+2%	+$5.68K	0.04%	198
2018 Q3	$260K	Sell	3,375 -120	-3%	-$8.87K	0.03%	202
2018 Q2	$236K	Hold	3,495	–	–	0.03%	211
2018 Q1	$254K	Sell	3,495 -87	-2%	-$6.62K	0.03%	205
2017 Q4	$269K	Buy	3,582 +269	+8%	+$20.3K	0.03%	206
2017 Q3	$254K	Sell	3,313 -3,277	-50%	-$247K	0.03%	209
2017 Q2	$492K	Sell	6,590 -6,456	-49%	-$458K	0.06%	158
2017 Q1	$868K	Buy	13,046 +524	+4%	+$34.9K	0.11%	165
2016 Q4	$818K	Sell	12,522 -5,251	-30%	-$341K	0.11%	165
2016 Q3	$1.26M	Sell	17,773 -6,571	-27%	-$479K	0.17%	125
2016 Q2	$1.8M	Sell	24,344 -1,520	-6%	-$105K	0.27%	99
2016 Q1	$1.68M	Buy	25,864 +22,738	+727%	+$1.55M	0.25%	108
2015 Q4	$240K	Hold	3,126	–	–	0.07%	175
2015 Q3	$257K	Hold	3,126	–	–	0.07%	171
2015 Q2	$275K	Hold	3,126	–	–	0.07%	175
2015 Q1	$276K	Buy	3,126 +391	+14%	+$34.7K	0.08%	173
2014 Q4	$227K	Sell	2,735 -97	-3%	-$8.04K	0.07%	182
2014 Q3	$239K	Buy	2,832 +111	+4%	+$8.98K	0.07%	183
2014 Q2	$221K	Buy	2,721 +39	+1%	+$3.07K	0.07%	184
2014 Q1	$204K	Buy	+2,682	New	+$195K	0.06%	180

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

AT Bancorp's NVS Position: Q1 2019 in Review

AT Bancorp reduced its Novartis (NVS) stake by 6.6% in Q1 2019, selling an estimated $18.3K and leaving 3,220 shares worth $277K. The position accounts for 0.03% of the portfolio, ranked #206.

AT Bancorp first reported a position in NVS in Q1 2014 and has held it in 21 quarters since. The position peaked at $1.8M in Q2 2016. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2019.

AT Bancorp held 3,220 shares of Novartis worth $277K as of Q1 2019.
AT Bancorp sold 228 Novartis shares in Q1 2019, an estimated $18.3K.
Novartis made up 0.03% of AT Bancorp's portfolio in Q1 2019, its #206 holding.
AT Bancorp first reported a position in Novartis in Q1 2014 and has held it in 21 quarters since.
AT Bancorp's Novartis position peaked at $1.8M in Q2 2016.
1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2019.

Based on AT Bancorp's 13F filing for Q1 2019, filed 13 May 2019.